Allison Torgesen
About Allison Torgesen
Allison Torgesen serves as the Director of Quality Control at Bolt Biotherapeutics, Inc., bringing over 20 years of experience in pharmaceutical quality control and drug development processes.
Work at Bolt Biotherapeutics
Allison Torgesen serves as the Director of Quality Control at Bolt Biotherapeutics, Inc. since 2023. In this role, she oversees quality control operations, ensuring compliance with industry standards and regulations. Her position is based in the San Francisco Bay Area, with a remote work option. Torgesen's leadership in quality control is integral to the company's mission of advancing innovative biotherapeutic solutions.
Previous Experience in Quality Control
Before joining Bolt Biotherapeutics, Torgesen held several key positions in quality control across various organizations. She was the QC Department Head at Fred Hutch from 2019 to 2020. Prior to that, she worked at Partner Therapeutics as QC Associate Director/Department Head from 2020 to 2023. Her extensive experience includes roles at Seattle Genetics, where she served as QC Manager, Sr. QC Analyst, and QC Scientist, as well as positions at Amgen and Genentech.
Education and Expertise
Allison Torgesen holds a Bachelor of Science degree in Biochemistry from Western Washington University. She furthered her education at the University of Washington, where she achieved a Biomedical Regulatory Affairs certification (RAC) from 2018 to 2019. Torgesen possesses over 20 years of experience in the pharmaceutical industry, with a strong focus on drug development processes and quality control operations.
Background in Pharmaceutical Quality Control
Torgesen has a robust background in pharmaceutical quality control, with a specific emphasis on aseptic drug substance and sterile parenteral pharmaceuticals. Her career spans over two decades, during which she has developed extensive knowledge of manufacturing and testing operations. This expertise is critical for advancing drugs to marketing approval and ensuring product safety and efficacy.